I nailed a 450% gain today on the call options for ILMN. The big news today was that Roche made a hostile takeover bid for the stock.
The reason is simple: the new gene sequencer machine that can map an entire genome in a day for between $1000 and $3000.
Think about this folks. Bloomberg did a research report where they showed how the first human genome took 11 years to map for a cost of $2.5 billion back in 2001. At the end of 2010, just 3,000 people have had their entire genome mapped. Costs during this time fell to $40,000... then $10,000... then $4,000. By the end of 2011, 30,000 people have had their genome mapped. ILMN and LIFE just announced that they'll start selling machines that can map an entire genome in 1 day for about $1,000. Wow!
But it's more than just entire genome mapping. Just last week, the news broke on a woman who had battled cancer for more than a year. Doctors did a genome map of her cancerous tumor. They identified weaknesses in the DNA and what cancer drugs would work best. Today, she's a happy mother and her cancer is gone. Now there is some caution here folks. Not every type of cancer can be better targeted via genome mapping. Nevertheless, cancer research scientists are all rushing to map the genomes of tumors in the hopes of developing better drugs.
No wonder Roche, a Swiss giant, moved in to gobble up ILMN. The potential going forward for these genome equipment makers is enormous.
But ILM has already spiked up on the Roche hostile takeover bid so we're out for a 450% gain in just 4 days. A big congratulations if you were able to follow me on this trade.
I'm not done in this sector though. My next buy this morning was LIFE. They are the only other company to ILMN that has created a genome sequencing machine that can sequence an entire genome in less than 1 day for a cost of $1,000. Even better, LIFE's sequencing machine will cost $149,000 while ILMN's machine will cost around $740,000.
Now think about it. If Roche is interested in purchase a cutting edge genome sequencing machine maker like ILMN, you can bet your bottom dollar that other big companies like Johnson and Johnson, GE, Siemens, Abbott, and Phillips are thinking about it to. Hence that's the profit thesis on my latest pick LIFE. In other words, I expect M&A activity to occur within the genome sequencing machine makers sector.
I nailed a 450% gain today on the call options for ILMN. The big news today was that Roche made a hostile takeover bid for the stock.
The reason is simple: the new gene sequencer machine that can map an entire genome in a day for between $1000 and $3000.
Think about this folks. Bloomberg did a research report where they showed how the first human genome took 11 years to map for a cost of $2.5 billion back in 2001. At the end of 2010, just 3,000 people have had their entire genome mapped. Costs during this time fell to $40,000... then $10,000... then $4,000. By the end of 2011, 30,000 people have had their genome mapped. ILMN and LIFE just announced that they'll start selling machines that can map an entire genome in 1 day for about $1,000. Wow!
But it's more than just entire genome mapping. Just last week, the news broke on a woman who had battled cancer for more than a year. Doctors did a genome map of her cancerous tumor. They identified weaknesses in the DNA and what cancer drugs would work best. Today, she's a happy mother and her cancer is gone. Now there is some caution here folks. Not every type of cancer can be better targeted via genome mapping. Nevertheless, cancer research scientists are all rushing to map the genomes of tumors in the hopes of developing better drugs.
No wonder Roche, a Swiss giant, moved in to gobble up ILMN. The potential going forward for these genome equipment makers is enormous.
But ILM has already spiked up on the Roche hostile takeover bid so we're out for a 450% gain in just 4 days. A big congratulations if you were able to follow me on this trade.
I'm not done in this sector though. My next buy this morning was LIFE. They are the only other company to ILMN that has created a genome sequencing machine that can sequence an entire genome in less than 1 day for a cost of $1,000. Even better, LIFE's sequencing machine will cost $149,000 while ILMN's machine will cost around $740,000.
Now think about it. If Roche is interested in purchase a cutting edge genome sequencing machine maker like ILMN, you can bet your bottom dollar that other big companies like Johnson and Johnson, GE, Siemens, Abbott, and Phillips are thinking about it to. Hence that's the profit thesis on my latest pick LIFE. In other words, I expect M&A activity to occur within the genome sequencing machine makers sector.
For a FREE DAILY EMAIL ALERT on the trend of Life Technologies (LIFE) click here! Just leave NASDAQ_LIFE in for the symbol and enter your name and email address!For a FREE DAILY EMAIL ALERT on the trend of Life Technologies (LIFE) click here! Just leave NASDAQ_LIFE in for the symbol and enter your name and email address!
I nailed a 450% gain today on the call options for ILMN. The big news today was that Roche made a hostile takeover bid for the stock.
The reason is simple: the new gene sequencer machine that can map an entire genome in a day for between $1000 and $3000.
Think about this folks. Bloomberg did a research report where they showed how the first human genome took 11 years to map for a cost of $2.5 billion back in 2001. At the end of 2010, just 3,000 people have had their entire genome mapped. Costs during this time fell to $40,000... then $10,000... then $4,000. By the end of 2011, 30,000 people have had their genome mapped. ILMN and LIFE just announced that they'll start selling machines that can map an entire genome in 1 day for about $1,000. Wow!
But it's more than just entire genome mapping. Just last week, the news broke on a woman who had battled cancer for more than a year. Doctors did a genome map of her cancerous tumor. They identified weaknesses in the DNA and what cancer drugs would work best. Today, she's a happy mother and her cancer is gone. Now there is some caution here folks. Not every type of cancer can be better targeted via genome mapping. Nevertheless, cancer research scientists are all rushing to map the genomes of tumors in the hopes of developing better drugs.
No wonder Roche, a Swiss giant, moved in to gobble up ILMN. The potential going forward for these genome equipment makers is enormous.
But ILM has already spiked up on the Roche hostile takeover bid so we're out for a 450% gain in just 4 days. A big congratulations if you were able to follow me on this trade.
I'm not done in this sector though. My next buy this morning was LIFE. They are the only other company to ILMN that has created a genome sequencing machine that can sequence an entire genome in less than 1 day for a cost of $1,000. Even better, LIFE's sequencing machine will cost $149,000 while ILMN's machine will cost around $740,000.
Now think about it. If Roche is interested in purchase a cutting edge genome sequencing machine maker like ILMN, you can bet your bottom dollar that other big companies like Johnson and Johnson, GE, Siemens, Abbott, and Phillips are thinking about it to. Hence that's the profit thesis on my latest pick LIFE. In other words, I expect M&A activity to occur within the genome sequencing machine makers sector.
For a FREE DAILY EMAIL ALERT on the trend of Life Technologies (LIFE) click here! Just leave NASDAQ_LIFE in for the symbol and enter your name and email address!For a FREE DAILY EMAIL ALERT on the trend of Life Technologies (LIFE) click here! Just leave NASDAQ_LIFE in for the symbol and enter your name and email address!
You guys know that I'm not a fan of Goldman Sachs and JP Morgan and how they are the underwriters on many of these tech companies going public. They set the initial IPO too high. They hype the IPO too much. And they should go to jail for using their stock analysts to rate the stock a buy based on flimsy bogus logic, and non-existent numbers.
Former New York Attorney General Eliot Spitzer fought to fix the situation by forcing companies like Goldman Sachs and JP Morgan to only compensate their stock analysts from non-IPO funds. Of course the big power financial firms didn't like Spitzer and ultimately they helped take him down by using Fox News and a prostitute scandal. With Spitzer gone, powerful firms like Goldman Sachs and JP Morgan went back to publishing bogus analyst reports on companies they took public.
Goldman Sachs and Morgan Stanley are two companies that took Zynga public, being paid some $33 million dollars for their efforts. Mutual Funds managed by Morgan Stanley, then invested in Zynga at $14 per share. In other words, if you hire Morgan Stanley to take your company public, they won't just hype the stock. They won't just produce bogus analyst ratings reports trying to suck in amateur traders like you and I. No, they'll even direct client funds in their managed Mutual Funds division to actually buy the stock and pump up the price.
Last week, the Macquarie Group and analyst Ben Schachter stepped in with some truth. The Macquarie Group was not an original underwriter of the Zynga IPO. The Macquarie Group had the guts to come out and publish what many of us have already known, Zynga relies on too small a number of customers for the majority of its revenue therefore it's a very risky speculative stock.
But the Macquarie Group didn't just stop there. They conducted their own independent research, that is independent of the underwriters of the Zynga IPO, and it turns out only 2% of Zynga's 150 million users pay to play its games! That's right. Goldman Sachs, JP Morgan, Morgan Stanley, Barclay's and Bank of America all were paid to take the company public, and all pumped the stock in bogus analyst reports that made up huge forecasted revenue numbers based on Zynga's current 150 million users customer base but in reality, 98% of those 150 million users are not really customers at all but just people taking advantage of a free game. If someone is not paying you, can you really classify them as a customer? No. Their a prospect until they actually become a customer. The only customers Zynga actually has are a mere 2% of 150 million users or just 3 million paying customers. But it get's even worse folks. Of those 3 million actual customers of Zynga, just 680,000 account for over 70% of Zynga's $800 million annual revenue.
Now Morgan Stanley had it's mutual funds buy Zynga, a company it was paid to take public, at $14 per share. Today the stock trades at about $9 per share, down a whopping 35% for those poor folks that hold Morgan Stanley mutual funds in their 401Ks and retirement programs.
You guys know that I'm not a fan of Goldman Sachs and JP Morgan and how they are the underwriters on many of these tech companies going public. They set the initial IPO too high. They hype the IPO too much. And they should go to jail for using their stock analysts to rate the stock a buy based on flimsy bogus logic, and non-existent numbers.
Former New York Attorney General Eliot Spitzer fought to fix the situation by forcing companies like Goldman Sachs and JP Morgan to only compensate their stock analysts from non-IPO funds. Of course the big power financial firms didn't like Spitzer and ultimately they helped take him down by using Fox News and a prostitute scandal. With Spitzer gone, powerful firms like Goldman Sachs and JP Morgan went back to publishing bogus analyst reports on companies they took public.
Goldman Sachs and Morgan Stanley are two companies that took Zynga public, being paid some $33 million dollars for their efforts. Mutual Funds managed by Morgan Stanley, then invested in Zynga at $14 per share. In other words, if you hire Morgan Stanley to take your company public, they won't just hype the stock. They won't just produce bogus analyst ratings reports trying to suck in amateur traders like you and I. No, they'll even direct client funds in their managed Mutual Funds division to actually buy the stock and pump up the price.
Last week, the Macquarie Group and analyst Ben Schachter stepped in with some truth. The Macquarie Group was not an original underwriter of the Zynga IPO. The Macquarie Group had the guts to come out and publish what many of us have already known, Zynga relies on too small a number of customers for the majority of its revenue therefore it's a very risky speculative stock.
But the Macquarie Group didn't just stop there. They conducted their own independent research, that is independent of the underwriters of the Zynga IPO, and it turns out only 2% of Zynga's 150 million users pay to play its games! That's right. Goldman Sachs, JP Morgan, Morgan Stanley, Barclay's and Bank of America all were paid to take the company public, and all pumped the stock in bogus analyst reports that made up huge forecasted revenue numbers based on Zynga's current 150 million users customer base but in reality, 98% of those 150 million users are not really customers at all but just people taking advantage of a free game. If someone is not paying you, can you really classify them as a customer? No. Their a prospect until they actually become a customer. The only customers Zynga actually has are a mere 2% of 150 million users or just 3 million paying customers. But it get's even worse folks. Of those 3 million actual customers of Zynga, just 680,000 account for over 70% of Zynga's $800 million annual revenue.
Now Morgan Stanley had it's mutual funds buy Zynga, a company it was paid to take public, at $14 per share. Today the stock trades at about $9 per share, down a whopping 35% for those poor folks that hold Morgan Stanley mutual funds in their 401Ks and retirement programs.
You guys know that I'm not a fan of Goldman Sachs and JP Morgan and how they are the underwriters on many of these tech companies going public. They set the initial IPO too high. They hype the IPO too much. And they should go to jail for using their stock analysts to rate the stock a buy based on flimsy bogus logic, and non-existent numbers.
Former New York Attorney General Eliot Spitzer fought to fix the situation by forcing companies like Goldman Sachs and JP Morgan to only compensate their stock analysts from non-IPO funds. Of course the big power financial firms didn't like Spitzer and ultimately they helped take him down by using Fox News and a prostitute scandal. With Spitzer gone, powerful firms like Goldman Sachs and JP Morgan went back to publishing bogus analyst reports on companies they took public.
Goldman Sachs and Morgan Stanley are two companies that took Zynga public, being paid some $33 million dollars for their efforts. Mutual Funds managed by Morgan Stanley, then invested in Zynga at $14 per share. In other words, if you hire Morgan Stanley to take your company public, they won't just hype the stock. They won't just produce bogus analyst ratings reports trying to suck in amateur traders like you and I. No, they'll even direct client funds in their managed Mutual Funds division to actually buy the stock and pump up the price.
Last week, the Macquarie Group and analyst Ben Schachter stepped in with some truth. The Macquarie Group was not an original underwriter of the Zynga IPO. The Macquarie Group had the guts to come out and publish what many of us have already known, Zynga relies on too small a number of customers for the majority of its revenue therefore it's a very risky speculative stock.
But the Macquarie Group didn't just stop there. They conducted their own independent research, that is independent of the underwriters of the Zynga IPO, and it turns out only 2% of Zynga's 150 million users pay to play its games! That's right. Goldman Sachs, JP Morgan, Morgan Stanley, Barclay's and Bank of America all were paid to take the company public, and all pumped the stock in bogus analyst reports that made up huge forecasted revenue numbers based on Zynga's current 150 million users customer base but in reality, 98% of those 150 million users are not really customers at all but just people taking advantage of a free game. If someone is not paying you, can you really classify them as a customer? No. Their a prospect until they actually become a customer. The only customers Zynga actually has are a mere 2% of 150 million users or just 3 million paying customers. But it get's even worse folks. Of those 3 million actual customers of Zynga, just 680,000 account for over 70% of Zynga's $800 million annual revenue.
Now Morgan Stanley had it's mutual funds buy Zynga, a company it was paid to take public, at $14 per share. Today the stock trades at about $9 per share, down a whopping 35% for those poor folks that hold Morgan Stanley mutual funds in their 401Ks and retirement programs.
I bought Illumina (ILMN) in my own trading account last week. If you follow me on Twitter then you'll know when I bought it within seconds of my doing so. Here's why.
Illumina, Inc. (ILMN) develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
Illumina (ILMN) is in the human genome sequencing business. They sell the equipment that allows a lab to sequence your entire genome. Just a few years ago, the cost of doing this was about $48,000. Today, the cost is expected to drop to $4,000 later this year. Within 5 years time, the cost is expected to drop to $1,000. At these lower costs, it is expected that insurance companies will cover genome sequencing and that it will be standard procedure to sequence every new born.
The future is human genome sequencing.
On 10/25/2011, ILMN reported 3 quarter 2011 earnings of $0.22 per share. This result was in-line with the consensus of the 23 analysts following the company and missed last year's 3 quarter results by 26.67%.
The next tentative earnings announcement is expected on Monday, 01/09/2012. On Monday, we'll find out if the consensus of the 24 analysts covering Illumina (ILMN) for Q4 2011 are right about their per share value of $0.27
ILMN's PE ratio is among the highest of any stock in the Scientific & Technical Instr. industry and signals that investors have high hopes for this company's future business prospects. Additionally, during the past year, earnings growth has outpaced its historical five year growth rate.
My profit thesis on ILMN is that it's a turn around play candidate. The turn around play profit thesis is a longer term profit thesis than are usual 3 to 10 day hold time.
ILMN announced last week that they hired Marc Stapley as their new Senior Vice President and CFO. Mr. Stapley was the former VP of Pfizer! This is huge news for the company and supports the turn around play profit thesis on the stock. ILMN spent two and half years looking for the right VP and CFO.
I bought Illumina (ILMN) in my own trading account last week. If you follow me on Twitter then you'll know when I bought it within seconds of my doing so. Here's why.
Illumina, Inc. (ILMN) develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
Illumina (ILMN) is in the human genome sequencing business. They sell the equipment that allows a lab to sequence your entire genome. Just a few years ago, the cost of doing this was about $48,000. Today, the cost is expected to drop to $4,000 later this year. Within 5 years time, the cost is expected to drop to $1,000. At these lower costs, it is expected that insurance companies will cover genome sequencing and that it will be standard procedure to sequence every new born.
The future is human genome sequencing.
On 10/25/2011, ILMN reported 3 quarter 2011 earnings of $0.22 per share. This result was in-line with the consensus of the 23 analysts following the company and missed last year's 3 quarter results by 26.67%.
The next tentative earnings announcement is expected on Monday, 01/09/2012. On Monday, we'll find out if the consensus of the 24 analysts covering Illumina (ILMN) for Q4 2011 are right about their per share value of $0.27
ILMN's PE ratio is among the highest of any stock in the Scientific & Technical Instr. industry and signals that investors have high hopes for this company's future business prospects. Additionally, during the past year, earnings growth has outpaced its historical five year growth rate.
My profit thesis on ILMN is that it's a turn around play candidate. The turn around play profit thesis is a longer term profit thesis than are usual 3 to 10 day hold time.
ILMN announced last week that they hired Marc Stapley as their new Senior Vice President and CFO. Mr. Stapley was the former VP of Pfizer! This is huge news for the company and supports the turn around play profit thesis on the stock. ILMN spent two and half years looking for the right VP and CFO.
For a FREE DAILY EMAIL ALERT on the trend of Illumina (ILMN) click here! Just leave NASDAQ_ILMN in for the symbol and enter your name and email address!For a FREE DAILY EMAIL ALERT on the trend of Illumina (ILMN) click here! Just leave NASDAQ_ILMN in for the symbol and enter your name and email address!
I bought Illumina (ILMN) in my own trading account last week. If you follow me on Twitter then you'll know when I bought it within seconds of my doing so. Here's why.
Illumina, Inc. (ILMN) develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
Illumina (ILMN) is in the human genome sequencing business. They sell the equipment that allows a lab to sequence your entire genome. Just a few years ago, the cost of doing this was about $48,000. Today, the cost is expected to drop to $4,000 later this year. Within 5 years time, the cost is expected to drop to $1,000. At these lower costs, it is expected that insurance companies will cover genome sequencing and that it will be standard procedure to sequence every new born.
The future is human genome sequencing.
On 10/25/2011, ILMN reported 3 quarter 2011 earnings of $0.22 per share. This result was in-line with the consensus of the 23 analysts following the company and missed last year's 3 quarter results by 26.67%.
The next tentative earnings announcement is expected on Monday, 01/09/2012. On Monday, we'll find out if the consensus of the 24 analysts covering Illumina (ILMN) for Q4 2011 are right about their per share value of $0.27
ILMN's PE ratio is among the highest of any stock in the Scientific & Technical Instr. industry and signals that investors have high hopes for this company's future business prospects. Additionally, during the past year, earnings growth has outpaced its historical five year growth rate.
My profit thesis on ILMN is that it's a turn around play candidate. The turn around play profit thesis is a longer term profit thesis than are usual 3 to 10 day hold time.
ILMN announced last week that they hired Marc Stapley as their new Senior Vice President and CFO. Mr. Stapley was the former VP of Pfizer! This is huge news for the company and supports the turn around play profit thesis on the stock. ILMN spent two and half years looking for the right VP and CFO.
For a FREE DAILY EMAIL ALERT on the trend of Illumina (ILMN) click here! Just leave NASDAQ_ILMN in for the symbol and enter your name and email address!For a FREE DAILY EMAIL ALERT on the trend of Illumina (ILMN) click here! Just leave NASDAQ_ILMN in for the symbol and enter your name and email address!
By new executive order of the President, Mitt Romney, at 1:00 PM each and every day, the public announcement system will signal a minute of pause as every American is now required to pick up their smartphone and read the edifying God tweet that will be sent to every smartphone.
Think this could never happen? Not if Westboro Church and the republican bible thumpers have their way.
Westboro Church said it will be protesting Steve Jobs funeral. You know those pictures of "Christians" who stand around holding signs that say doggy poop like "God Hates Fags"? Yeah, let's all roll our eyes together, those guys.
The Westboro Baptist Church is not recognized by any Baptist organizations. That's right, even the whacky Southern Baptists who preach fire and brimstone on the immoral lifestyle of sinners, which is 100% of people who aren't Baptist, look at these guys and say no way are we getting mixed up with that craziness.
Apparently, Steve Jobs crime is that he invented a very popular mobile smartphone and he didn't use it to glorify God. After the hypocrisy of Westboro Church using an iPhone, to tweet about the Steve Jobs protest, was pointed out, Westboro Church replied that no, it was not hypocrisy that they were using the same evil device they were condemning Steve Jobs for, no, in fact, they were using the iPhone in a way that it should have been used all along, to spread God's hate.
Imagine if we lived in a world where religion was forced onto everyone. Where even the iPhone would be under attack by the government because it was not used enough to glorify God. Where at noon everyday, everyone had to stop what they were doing, like what the Muslims do, as they get a mandatory tweet over their iPhone about how great the invisible man who lives in the clouds is.
Yee haw, Jesus take the wheel.
By new executive order of the President, Mitt Romney, at 1:00 PM each and every day, the public announcement system will signal a minute of pause as every American is now required to pick up their smartphone and read the edifying God tweet that will be sent to every smartphone.
Think this could never happen? Not if Westboro Church and the republican bible thumpers have their way.
Westboro Church said it will be protesting Steve Jobs funeral. You know those pictures of "Christians" who stand around holding signs that say doggy poop like "God Hates Fags"? Yeah, let's all roll our eyes together, those guys.
The Westboro Baptist Church is not recognized by any Baptist organizations. That's right, even the whacky Southern Baptists who preach fire and brimstone on the immoral lifestyle of sinners, which is 100% of people who aren't Baptist, look at these guys and say no way are we getting mixed up with that craziness.
Apparently, Steve Jobs crime is that he invented a very popular mobile smartphone and he didn't use it to glorify God. After the hypocrisy of Westboro Church using an iPhone, to tweet about the Steve Jobs protest, was pointed out, Westboro Church replied that no, it was not hypocrisy that they were using the same evil device they were condemning Steve Jobs for, no, in fact, they were using the iPhone in a way that it should have been used all along, to spread God's hate.
Imagine if we lived in a world where religion was forced onto everyone. Where even the iPhone would be under attack by the government because it was not used enough to glorify God. Where at noon everyday, everyone had to stop what they were doing, like what the Muslims do, as they get a mandatory tweet over their iPhone about how great the invisible man who lives in the clouds is.
Yee haw, Jesus take the wheel.
By new executive order of the President, Mitt Romney, at 1:00 PM each and every day, the public announcement system will signal a minute of pause as every American is now required to pick up their smartphone and read the edifying God tweet that will be sent to every smartphone.
Think this could never happen? Not if Westboro Church and the republican bible thumpers have their way.
Westboro Church said it will be protesting Steve Jobs funeral. You know those pictures of "Christians" who stand around holding signs that say doggy poop like "God Hates Fags"? Yeah, let's all roll our eyes together, those guys.
The Westboro Baptist Church is not recognized by any Baptist organizations. That's right, even the whacky Southern Baptists who preach fire and brimstone on the immoral lifestyle of sinners, which is 100% of people who aren't Baptist, look at these guys and say no way are we getting mixed up with that craziness.
Apparently, Steve Jobs crime is that he invented a very popular mobile smartphone and he didn't use it to glorify God. After the hypocrisy of Westboro Church using an iPhone, to tweet about the Steve Jobs protest, was pointed out, Westboro Church replied that no, it was not hypocrisy that they were using the same evil device they were condemning Steve Jobs for, no, in fact, they were using the iPhone in a way that it should have been used all along, to spread God's hate.
Imagine if we lived in a world where religion was forced onto everyone. Where even the iPhone would be under attack by the government because it was not used enough to glorify God. Where at noon everyday, everyone had to stop what they were doing, like what the Muslims do, as they get a mandatory tweet over their iPhone about how great the invisible man who lives in the clouds is.
Yee haw, Jesus take the wheel.
You can learn a lot from the horrors of the natural world. There are some just outright evil creatures out there.
But at least the vast majority have the common decency to be upfront about the fact they can do us serious harm--claws, big teeth, bright colors. But not the tick. These guys can ruin your day, and you'll never see them coming.
Use the TICK, become the TICK.
So far, for the start of the fourth quarter, the semiconductor sector is attracting the most money followed closely behind by basic materials.
The reason that the start of the fourth quarter is so important is because it lets us see what institutional traders are doing. At the start of the fourth quarter, institutional traders, money managers, hedge fund managers, 401(k) managers, are positioning their portfolios for the fourth quarter. Therefore, the theory is that you can watch the sectors at the start of the fourth quarter that have the most money moving into them to get a pretty good idea of what the institutional traders are buying.
The semiconductors sector is the #1 performing sector so far for the fourth quarter which is why I have bought the Direxion Daily Semicondct Bull 3X Shares (SOXL) today in my own personal trading account.
The Stock Trader's Almanac says that at this time of year, the best sectors to go along are semiconductors and basic materials. This is precisely the two sectors we see with the most money flowing into them right now. This means that what we are seeing is the start of the typical seasonal trend and that gives us more confidence in taking long positions in these sectors.
My favorite blood sucking technical analysis indicator that lets me feed off of institutional traders is the TICK. If indeed the first one to two weeks in October are dominated by institutional buying, we would expect to see the TICK spike up above +800. This is exactly what we have seen with the TICK hitting +950 last week. This gives us the green light to jump into basic materials and semiconductors and suck the blood of the institutional traders until they swat us off.
You can learn a lot from the horrors of the natural world. There are some just outright evil creatures out there.
But at least the vast majority have the common decency to be upfront about the fact they can do us serious harm--claws, big teeth, bright colors. But not the tick. These guys can ruin your day, and you'll never see them coming.
Use the TICK, become the TICK.
So far, for the start of the fourth quarter, the semiconductor sector is attracting the most money followed closely behind by basic materials.
The reason that the start of the fourth quarter is so important is because it lets us see what institutional traders are doing. At the start of the fourth quarter, institutional traders, money managers, hedge fund managers, 401(k) managers, are positioning their portfolios for the fourth quarter. Therefore, the theory is that you can watch the sectors at the start of the fourth quarter that have the most money moving into them to get a pretty good idea of what the institutional traders are buying.
The semiconductors sector is the #1 performing sector so far for the fourth quarter which is why I have bought the Direxion Daily Semicondct Bull 3X Shares (SOXL) today in my own personal trading account.
For a FREE DAILY EMAIL ALERT on the trend of the Direxion Daily Semicondct Bull 3X Shares (SOXL) click here! Just leave PACF_SOXL in for the symbol and enter your name and email address!
The Stock Trader's Almanac says that at this time of year, the best sectors to go along are semiconductors and basic materials. This is precisely the two sectors we see with the most money flowing into them right now. This means that what we are seeing is the start of the typical seasonal trend and that gives us more confidence in taking long positions in these sectors.
My favorite blood sucking technical analysis indicator that lets me feed off of institutional traders is the TICK. If indeed the first one to two weeks in October are dominated by institutional buying, we would expect to see the TICK spike up above +800. This is exactly what we have seen with the TICK hitting +950 last week. This gives us the green light to jump into basic materials and semiconductors and suck the blood of the institutional traders until they swat us off.
For a FREE DAILY EMAIL ALERT on the trend of the Direxion Daily Semicondct Bull 3X Shares (SOXL) click here! Just leave PACF_SOXL in for the symbol and enter your name and email address!
You can learn a lot from the horrors of the natural world. There are some just outright evil creatures out there.
But at least the vast majority have the common decency to be upfront about the fact they can do us serious harm--claws, big teeth, bright colors. But not the tick. These guys can ruin your day, and you'll never see them coming.
Use the TICK, become the TICK.
So far, for the start of the fourth quarter, the semiconductor sector is attracting the most money followed closely behind by basic materials.
The reason that the start of the fourth quarter is so important is because it lets us see what institutional traders are doing. At the start of the fourth quarter, institutional traders, money managers, hedge fund managers, 401(k) managers, are positioning their portfolios for the fourth quarter. Therefore, the theory is that you can watch the sectors at the start of the fourth quarter that have the most money moving into them to get a pretty good idea of what the institutional traders are buying.
The semiconductors sector is the #1 performing sector so far for the fourth quarter which is why I have bought the Direxion Daily Semicondct Bull 3X Shares (SOXL) today in my own personal trading account.
For a FREE DAILY EMAIL ALERT on the trend of the Direxion Daily Semicondct Bull 3X Shares (SOXL) click here! Just leave PACF_SOXL in for the symbol and enter your name and email address!
The Stock Trader's Almanac says that at this time of year, the best sectors to go along are semiconductors and basic materials. This is precisely the two sectors we see with the most money flowing into them right now. This means that what we are seeing is the start of the typical seasonal trend and that gives us more confidence in taking long positions in these sectors.
My favorite blood sucking technical analysis indicator that lets me feed off of institutional traders is the TICK. If indeed the first one to two weeks in October are dominated by institutional buying, we would expect to see the TICK spike up above +800. This is exactly what we have seen with the TICK hitting +950 last week. This gives us the green light to jump into basic materials and semiconductors and suck the blood of the institutional traders until they swat us off.
For a FREE DAILY EMAIL ALERT on the trend of the Direxion Daily Semicondct Bull 3X Shares (SOXL) click here! Just leave PACF_SOXL in for the symbol and enter your name and email address!
Hey folks, do I have a hot stock pick for you! The company is called RTI Biologics, Inc. (RTIX). They are a biomedical company. They produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.
The rumor is that Wall Street analysts are beginning to follow the stock but as yet haven't published any buy signals. You can see some of this added coverage from Wall Street analysts by studying the volume of this chart. The volume has steadily increased over the last four months. I also like the upgrade coming from The Benchmark Company. RTI Biologics, Inc. (RTIX) has also been upgraded by Craig-Hallum with a 1 year price target of $5.
Analysts project earnings to grow by 30% this year.
Below is a smooth music video that I made for you guys. Who says stock research has to be boring? I bought this stock for my own trading account on September 20th, 2011 at $3.51 per share.
Hey folks, do I have a hot stock pick for you! The company is called RTI Biologics, Inc. (RTIX). They are a biomedical company. They produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.
The rumor is that Wall Street analysts are beginning to follow the stock but as yet haven't published any buy signals. You can see some of this added coverage from Wall Street analysts by studying the volume of this chart. The volume has steadily increased over the last four months. I also like the upgrade coming from The Benchmark Company. RTI Biologics, Inc. (RTIX) has also been upgraded by Craig-Hallum with a 1 year price target of $5.
Analysts project earnings to grow by 30% this year.
Market Club has just given this company a weekly buy triangle and a strong uptrend rating. For a FREE DAILY EMAIL ALERT on the trend of RTI Biologics, Inc. (RTIX) click here! Just leave NASDAQ_RTIX in for the symbol and enter your name and email address!
The stock also has just done a flag breakout.
Below is a smooth music video that I made for you guys. Who says stock research has to be boring? I bought this stock for my own trading account on September 20th, 2011 at $3.51 per share.
For a FREE DAILY EMAIL ALERT on the trend of RTI Biologics, Inc. (RTIX) click here! Just leave NASDAQ_RTIX in for the symbol and enter your name and email address!
Hey folks, do I have a hot stock pick for you! The company is called RTI Biologics, Inc. (RTIX). They are a biomedical company. They produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.
The rumor is that Wall Street analysts are beginning to follow the stock but as yet haven't published any buy signals. You can see some of this added coverage from Wall Street analysts by studying the volume of this chart. The volume has steadily increased over the last four months. I also like the upgrade coming from The Benchmark Company. RTI Biologics, Inc. (RTIX) has also been upgraded by Craig-Hallum with a 1 year price target of $5.
Analysts project earnings to grow by 30% this year.
Market Club has just given this company a weekly buy triangle and a strong uptrend rating. For a FREE DAILY EMAIL ALERT on the trend of RTI Biologics, Inc. (RTIX) click here! Just leave NASDAQ_RTIX in for the symbol and enter your name and email address!
The stock also has just done a flag breakout.
Below is a smooth music video that I made for you guys. Who says stock research has to be boring? I bought this stock for my own trading account on September 20th, 2011 at $3.51 per share.
For a FREE DAILY EMAIL ALERT on the trend of RTI Biologics, Inc. (RTIX) click here! Just leave NASDAQ_RTIX in for the symbol and enter your name and email address!
Burger King has announced they are dropping "The King" from their marketing.
The bosses at Burger King have said that McDonald's has done better than they have since they brought the King back in their marketing in 2003.
I loved the King's funny commercials and I think he's getting a bum rap.
Burger King says its new ads will be about healthier eating and its commercials will feature no words, only music, with images of the burger's ingredients being washed and prepped.
Yeah, that's gonna turn things around for Burger King with their memorable new healthy ad line up, NOT!
Burger King's problem is not The King. Competitors are beating them because they've updated and expanded their menus while Burger King has mostly stuck to its menu of burgers and fries.
McDonald's has worked to change their image to a healthier, cool place to eat, offering wireless access in restaurants, updating decor and introducing smoothies, fish, oatmeal and yogurt parfaits.
Burger King has announced they are dropping "The King" from their marketing.
The bosses at Burger King have said that McDonald's has done better than they have since they brought the King back in their marketing in 2003.
I loved the King's funny commercials and I think he's getting a bum rap.
Burger King says its new ads will be about healthier eating and its commercials will feature no words, only music, with images of the burger's ingredients being washed and prepped.
Yeah, that's gonna turn things around for Burger King with their memorable new healthy ad line up, NOT!
Burger King's problem is not The King. Competitors are beating them because they've updated and expanded their menus while Burger King has mostly stuck to its menu of burgers and fries.
McDonald's has worked to change their image to a healthier, cool place to eat, offering wireless access in restaurants, updating decor and introducing smoothies, fish, oatmeal and yogurt parfaits.
Burger King has announced they are dropping "The King" from their marketing.
The bosses at Burger King have said that McDonald's has done better than they have since they brought the King back in their marketing in 2003.
I loved the King's funny commercials and I think he's getting a bum rap.
Burger King says its new ads will be about healthier eating and its commercials will feature no words, only music, with images of the burger's ingredients being washed and prepped.
Yeah, that's gonna turn things around for Burger King with their memorable new healthy ad line up, NOT!
Burger King's problem is not The King. Competitors are beating them because they've updated and expanded their menus while Burger King has mostly stuck to its menu of burgers and fries.
McDonald's has worked to change their image to a healthier, cool place to eat, offering wireless access in restaurants, updating decor and introducing smoothies, fish, oatmeal and yogurt parfaits.
Abercrombie & Fitch (ANF) made a huge amount of buzz last week when they did a press release announcing their concern that having Jersey Shorestar Mike "The Situation" Sorrentino seen in its clothing could cause significant damage to the company’s image. They even offered to pay stars of The Situation if they stopped wearing their clothes.
Abercrombie & Fitch is all about image. They don't hire darker skinned people because their not as pretty as white people, disabled people with prosthetic devices aren't as pretty as able bodied people, and everybody knows those muslims look ridiculous with those sheets on their heads.
But this can't be about image because Abercrombie & Fitch has released two lines of clothing just for The Situation MTV show. That's right. Abercrombie said in an earnings release that these were some of their best selling shirts for the quarter.
This was nothing more than a marketing stunt by Abercrombie to get their clothes associated with The Situation TV show. I mean who really watches The Situation and sees Mike and yells oh, that's an Abercrombie & Fitch shirt! Most people had no idea that stars on The Situation wear Abercrombie clothes until this fake drama news story broke last week.
Abercrombie & Fitch (ANF) made a huge amount of buzz last week when they did a press release announcing their concern that having Jersey Shorestar Mike "The Situation" Sorrentino seen in its clothing could cause significant damage to the company’s image. They even offered to pay stars of The Situation if they stopped wearing their clothes.
Abercrombie & Fitch is all about image. They don't hire darker skinned people because their not as pretty as white people, disabled people with prosthetic devices aren't as pretty as able bodied people, and everybody knows those muslims look ridiculous with those sheets on their heads.
But this can't be about image because Abercrombie & Fitch has released two lines of clothing just for The Situation MTV show. That's right. Abercrombie said in an earnings release that these were some of their best selling shirts for the quarter.
This was nothing more than a marketing stunt by Abercrombie to get their clothes associated with The Situation TV show. I mean who really watches The Situation and sees Mike and yells oh, that's an Abercrombie & Fitch shirt! Most people had no idea that stars on The Situation wear Abercrombie clothes until this fake drama news story broke last week.
Abercrombie & Fitch (ANF) made a huge amount of buzz last week when they did a press release announcing their concern that having Jersey Shorestar Mike "The Situation" Sorrentino seen in its clothing could cause significant damage to the company’s image. They even offered to pay stars of The Situation if they stopped wearing their clothes.
Abercrombie & Fitch is all about image. They don't hire darker skinned people because their not as pretty as white people, disabled people with prosthetic devices aren't as pretty as able bodied people, and everybody knows those muslims look ridiculous with those sheets on their heads.
But this can't be about image because Abercrombie & Fitch has released two lines of clothing just for The Situation MTV show. That's right. Abercrombie said in an earnings release that these were some of their best selling shirts for the quarter.
This was nothing more than a marketing stunt by Abercrombie to get their clothes associated with The Situation TV show. I mean who really watches The Situation and sees Mike and yells oh, that's an Abercrombie & Fitch shirt! Most people had no idea that stars on The Situation wear Abercrombie clothes until this fake drama news story broke last week.
Stocks Above I Currently Hold In My Own Trading Account: Long LIFE
Guerilla Trader Quote
“Institutions approach the market battlefield as an army with vastly superior weaponry that uses brute force and power to gain profits. Individual traders need to be like speedy hit and run guerilla forces: darting behind rock and tree before we get captured and take a loss.”
Copyright 2009-2011 GuerillaStockTrading.com All rights reserved. No part or article on this website may be copied or duplicated without written consent from GuerillaStockTrading.com and Confab Publishing. Disclaimer: This Web site is designed to provide accurate and authoritative information on the subject of personal finances. It is provided with the understanding that neither the author nor the publisher is engaged in rendering legal, accounting, or other professional services by providing this Web site. The authors and publisher shall not be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential or other damages. As each individual situation is unique, questions relevant to personal finances and specific to the individual should be addressed to an appropriate professional to ensure that the situation has been carefully and appropriately evaluated. This blog is for information and entertainment purposes only. Under no circumstances does this information represent a recommendation to buy or sell securities or any other type of investment instruments. See a licensed broker for investment advice.
I nailed a 450% gain today on the call options for ILMN. The big news today was that Roche made a hostile takeover bid for the stock.
You guys know that I'm not a fan of Goldman Sachs and JP Morgan and how they are the underwriters on many of these tech companies going public. They set the initial IPO too high. They hype the IPO too much. And they should go to jail for using their stock analysts to rate the stock a buy based on flimsy bogus logic, and non-existent numbers.
I bought Illumina (ILMN) in my own trading account last week. If you follow me on Twitter then you'll know when I bought it within seconds of my doing so. Here's why.
By new executive order of the President, Mitt Romney, at 1:00 PM each and every day, the public announcement system will signal a minute of pause as every American is now required to pick up their smartphone and read the edifying God tweet that will be sent to every smartphone. 
You can learn a lot from the horrors of the natural world. There are some just outright evil creatures out there.
Burger King has announced they are dropping "The King" from their marketing.
Abercrombie & Fitch (ANF) made a huge amount of buzz last week when they did a press release announcing their concern that having Jersey Shorestar Mike "The Situation" Sorrentino seen in its clothing could cause significant damage to the company’s image. They even offered to pay stars of The Situation if they stopped wearing their clothes.
Guerilla Stock Trading University